Skip to main content

Table 2 Oral CS burden (mg/kg/day) change

From: Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature

Time from 1st RTX

Median

Range

Significance from t = 0

t = 0

0.345

0–1.28

–

t = 6 months

0

0–0.5

p = 0.078

t = 1 year

0

0–0.2

p = 0.0625

t = 2 years

0

0

p = 0.03

  1. RTX rituximab; p-value calculated using paired Wilcoxon signed rank test; significance level p < 0.05
Back to article page

Pediatric Rheumatology

ISSN: 1546-0096